News and Media

Press Releases

01-15-2019 – Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections

12-18-2017 – Accelerate NY Seed Fund Awards Bioharmony Therapeutics $100,000 to Develop a Lysin-based Treatment for Skin Infections Caused by Multi-drug Resistant Acinetobacter baumanii

10-18-2016 –  Bioharmony Therapeutics Wins “Best in Show” at 1st Pitch Life Science
Competition

In The Media

11-15-2017 – Life Science Nation: Bioharmony Therapeutics wins second place at RESI Innovation Challenge in NYC

12-17-2017 – Newsday: Tech startups use $1M in funding to attract $24M in venture capital

02-20-2018 – Maddyness: Eight startups who want (and could well) change the world

01-16-2019 – Bioworld: Bioharmony, Boehringer to collaborate on lysin therapies for drug-resistant infections

08-01-2019 – Life Science Leader: Companies to Watch

12-01-2020 – Life Science Leader: Politics and the Pandemic — Where Are They Taking Biopharma? Industry CEOs Speak Out